{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:28:33Z","timestamp":1787506113631,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Fund Project of Baoji Health and Family Planning Bureau","award":["2016-08"],"award-info":[{"award-number":["2016-08"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study will appraise the clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease (AD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Comprehensive searches in PUBMED, EMBASE, Cochrane Library, Scopus, AMED, CNKI, and WANGFANG will be performed from inception to the present without language restriction. In addition, other sources will also be searched to avoid losing more potential studies. We will only consider randomized controlled trials that examined the efficacy of sertraline for depression in patients with AD. Two team members will independently undertake literature selection, data collection, and risk of bias assessment. We will use Cochrane Risk of Bias Tool to assess the risk of bias for each eligible trial, and will utilize RevMan 5.3 software to carry out data analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This study will recapitulate high-quality evidence to assess the efficacy of sertraline for the treatment of depression following AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings of this study will help to determine whether or not sertraline is effective for the treatment of depression after AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OSF registration:<\/jats:title>\n                    <jats:p>osf.io\/f29v6.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000023076","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T23:03:42Z","timestamp":1604531022000},"page":"e23076","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease"],"prefix":"10.1097","volume":"99","author":[{"given":"Wei-hua","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-wen","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Baoji Traditional Chinese Medicine Hospital, Baoji"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-8913","authenticated-orcid":false,"given":"Xiao-feng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Xi\u2019an Mental Health Center, Xi\u2019an, Shaanxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.307.6907.779","article-title":"Alzheimer's disease","volume":"307","author":"Rossor","year":"1993","journal-title":"BMJ"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bmj.316.7129.446","article-title":"Alzheimer's disease","volume":"316","author":"Masters","year":"1998","journal-title":"BMJ"},{"key":"R3-20230916","first-page":"a004457","article-title":"Alzheimer's disease","volume":"3","author":"Selko","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"(suppl 9)","key":"R4-20230916","first-page":"7","article-title":"Neuropathologic changes in Alzheimer's disease","volume":"64","author":"Wenk","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer's disease","volume":"15","author":"Jahn","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fpsyt.2019.00571","article-title":"Association of transfusion with risks of dementia or Alzheimer's disease: a population-based cohort study","volume":"10","author":"Lin","year":"2019","journal-title":"Front Psychiatry"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"e0179399","DOI":"10.1371\/journal.pone.0179399","article-title":"Depression in dementia with Lewy bodies: a comparison with Alzheimer's disease","volume":"12","author":"Chiu","year":"2017","journal-title":"PLoS One"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2741\/4170","article-title":"Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly","volume":"18","author":"Randall","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"9171424","DOI":"10.1155\/2019\/9171424","article-title":"Theories of aging and the prevalence of Alzheimer's disease","volume":"2019","author":"Trevisan","year":"2019","journal-title":"Biomed Res Int"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"e12802","DOI":"10.1111\/acel.12802","article-title":"Aging and Alzheimer's disease: comparison and associations from molecular to system level","volume":"17","author":"Xia","year":"2018","journal-title":"Aging Cell"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12264-017-0192-4","article-title":"Membrane aging as the real culprit of Alzheimer's disease: modification of a hypothesis","volume":"34","author":"Yu","year":"2018","journal-title":"Neurosci Bull"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/pgmj.2004.028290","article-title":"Cognitive aging and Alzheimer's disease","volume":"81","author":"Vandenberghe","year":"2005","journal-title":"Postgrad Med J"},{"key":"R13-20230916","first-page":"31","article-title":"The practice of filial piety and its impact on long-term care policies for elderly people in Asian Chinese communities","volume":"1","author":"Chow","year":"2006","journal-title":"Asian J Gerontol Geriatr"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/WAD.0000000000000147","article-title":"Temporal trends and geographic variations in dementia mortality in China between 2006 and 2012: multilevel evidence from a nationally representative sample","volume":"30","author":"Yin","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of antidepressants for depression in Alzheimer's disease: systematic review and meta-analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40120-019-00148-5","article-title":"Diagnosing and treating depression in patients with Alzheimer's disease","volume":"8","author":"Burke","year":"2019","journal-title":"Neurol Ther"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JAD-170964","article-title":"Separating symptomatic Alzheimer's disease from depression based on structural MRI","volume":"63","author":"Kl\u00f6ppel","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"26716","DOI":"10.18632\/oncotarget.5777","article-title":"Serotonin 6 receptor controls Alzheimer's disease and depression","volume":"6","author":"Yun","year":"2015","journal-title":"Oncotarget"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fphar.2019.01067","article-title":"Pharmacological treatment of depression in Alzheimer's disease: a challenging task","volume":"10","author":"Cassano","year":"2019","journal-title":"Front Pharmacol"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fpsyt.2019.00014","article-title":"The effects of acupuncture on glutamatergic neurotransmission in depression, anxiety, schizophrenia, and Alzheimer's disease: a review of the literature","volume":"10","author":"Tu","year":"2019","journal-title":"Front Psychiatry"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13063-017-2019-z","article-title":"Transcranial direct current stimulation for depression in Alzheimer's disease: study protocol for a randomized controlled trial","volume":"18","author":"Narita","year":"2017","journal-title":"Trials"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jagp.2013.02.014","article-title":"Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2","volume":"22","author":"Longmire","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-200247","article-title":"The Efficacy of sertraline, escitalopram, and nicergoline in the treatment of depression and apathy in Alzheimer's disease: the Okayama Depression and Apathy Project (ODAP)","volume":"76","author":"Takemoto","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/appi.ajp.157.10.1686","article-title":"Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00019442-200002000-00009","article-title":"controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease","volume":"8","author":"Magai","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/089198879400700406","article-title":"Treatment of depression in advanced Alzheimer's disease using sertraline","volume":"7","author":"Volicer","year":"1994","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:53:36Z","timestamp":1694814816000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023076"}},"subtitle":["A protocol of systematic review"],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":27,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023076","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]}}}